PL376022A1 - 2,4-Podstawione indole i ich zastosowanie jako modulatorów 5-HT6 - Google Patents
2,4-Podstawione indole i ich zastosowanie jako modulatorów 5-HT6Info
- Publication number
- PL376022A1 PL376022A1 PL03376022A PL37602203A PL376022A1 PL 376022 A1 PL376022 A1 PL 376022A1 PL 03376022 A PL03376022 A PL 03376022A PL 37602203 A PL37602203 A PL 37602203A PL 376022 A1 PL376022 A1 PL 376022A1
- Authority
- PL
- Poland
- Prior art keywords
- modulators
- substituted indoles
- indoles
- substituted
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41148002P | 2002-09-17 | 2002-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376022A1 true PL376022A1 (pl) | 2005-12-12 |
Family
ID=32030683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03376022A PL376022A1 (pl) | 2002-09-17 | 2003-09-08 | 2,4-Podstawione indole i ich zastosowanie jako modulatorów 5-HT6 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7381739B2 (pl) |
| EP (1) | EP1542973B1 (pl) |
| JP (1) | JP4267573B2 (pl) |
| KR (1) | KR100686757B1 (pl) |
| CN (1) | CN1301970C (pl) |
| AR (1) | AR041256A1 (pl) |
| AT (1) | ATE402923T1 (pl) |
| AU (1) | AU2003267063B2 (pl) |
| BR (1) | BR0314363A (pl) |
| CA (1) | CA2498946A1 (pl) |
| DE (1) | DE60322551D1 (pl) |
| ES (1) | ES2311721T3 (pl) |
| HR (1) | HRP20050213A2 (pl) |
| MX (1) | MXPA05002836A (pl) |
| NO (1) | NO20050664L (pl) |
| NZ (1) | NZ538047A (pl) |
| PA (1) | PA8582101A1 (pl) |
| PL (1) | PL376022A1 (pl) |
| RU (1) | RU2326112C2 (pl) |
| TW (1) | TWI250150B (pl) |
| UY (1) | UY27979A1 (pl) |
| WO (1) | WO2004026831A1 (pl) |
| ZA (1) | ZA200501175B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039127A1 (es) | 2002-03-27 | 2005-02-09 | Glaxo Group Ltd | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento |
| JP2006505559A (ja) * | 2002-10-18 | 2006-02-16 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ６受容体親和性を持つ４−ピペラジニルベンゼンスルホニルインドール |
| NZ544331A (en) | 2003-07-22 | 2010-03-26 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| EP1701940B1 (en) * | 2003-12-23 | 2008-05-28 | H.Lundbeck A/S | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| TWI380816B (zh) * | 2004-04-13 | 2013-01-01 | Synta Pharmaceuticals Corp | 抑制介白素-１２（ｉｌ-１２）生成之二鹽抑制劑 |
| AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| GB0422263D0 (en) * | 2004-10-07 | 2004-11-10 | Glaxo Group Ltd | Novel compounds |
| AR054393A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| US7629473B2 (en) * | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| MX2009004898A (es) * | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Derivados de indol y de benzofurano-2-carboxamida. |
| US20100087446A1 (en) * | 2007-04-26 | 2010-04-08 | Chakravarty Prasun K | 2-substituted indole derivatives as calcium channel blockers |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| US9499484B2 (en) * | 2012-04-02 | 2016-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Indole, indoline derivatives, compositions comprising them and uses thereof |
| CN104725295B (zh) | 2013-12-20 | 2019-05-24 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
| AU2015286049B2 (en) | 2014-07-08 | 2018-03-01 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
| CA2194984C (en) * | 1994-07-26 | 2002-07-02 | John Eugene Macor | 4-indole derivatives as serotonin agonists and antagonists |
| US6114532A (en) | 1998-02-03 | 2000-09-05 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals |
| AR019178A1 (es) | 1998-06-30 | 2001-12-26 | Lilly Co Eli | Compuestos de 7-(benzo(b)tiofeno, furan e indolpiridil o tetrahidropiridilo), efectivos sobre sistemas relacionados con la serotonina, composicionesfarmaceuticas formuladas con dichos compuestos; compuestos intermediarios utiles para preparar dichos compuestos de tiofeno, furan e indolpiridilo otetr |
| GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| KR100823908B1 (ko) * | 2000-10-20 | 2008-04-21 | 바이오비트럼 에이비(피유비엘) | 2-, 3-, 4-, 또는 5-치환-ｎ1-(벤젠술포닐)인돌 및 이의치료 용도 |
| EP1343756A2 (en) * | 2000-11-02 | 2003-09-17 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| ES2271124T3 (es) * | 2000-11-24 | 2007-04-16 | Smithkline Beecham Plc | Compuestos indolil-sulfonilicos utiles en el tratamiento de trastornos del snc. |
| US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
| JP4754821B2 (ja) | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物 |
-
2003
- 2003-09-08 PL PL03376022A patent/PL376022A1/pl not_active Application Discontinuation
- 2003-09-08 AU AU2003267063A patent/AU2003267063B2/en not_active Ceased
- 2003-09-08 DE DE60322551T patent/DE60322551D1/de not_active Expired - Lifetime
- 2003-09-08 MX MXPA05002836A patent/MXPA05002836A/es active IP Right Grant
- 2003-09-08 HR HR20050213A patent/HRP20050213A2/xx not_active Application Discontinuation
- 2003-09-08 EP EP03747986A patent/EP1542973B1/en not_active Expired - Lifetime
- 2003-09-08 AT AT03747986T patent/ATE402923T1/de not_active IP Right Cessation
- 2003-09-08 WO PCT/EP2003/009969 patent/WO2004026831A1/en not_active Ceased
- 2003-09-08 BR BR0314363-5A patent/BR0314363A/pt not_active IP Right Cessation
- 2003-09-08 NZ NZ538047A patent/NZ538047A/en unknown
- 2003-09-08 JP JP2004537019A patent/JP4267573B2/ja not_active Expired - Fee Related
- 2003-09-08 CA CA002498946A patent/CA2498946A1/en not_active Abandoned
- 2003-09-08 ES ES03747986T patent/ES2311721T3/es not_active Expired - Lifetime
- 2003-09-08 CN CNB03822044XA patent/CN1301970C/zh not_active Expired - Fee Related
- 2003-09-08 KR KR1020057004479A patent/KR100686757B1/ko not_active Expired - Fee Related
- 2003-09-08 RU RU2005111590/04A patent/RU2326112C2/ru not_active IP Right Cessation
- 2003-09-12 TW TW092125224A patent/TWI250150B/zh not_active IP Right Cessation
- 2003-09-12 PA PA20038582101A patent/PA8582101A1/es unknown
- 2003-09-15 AR ARP030103332A patent/AR041256A1/es not_active Application Discontinuation
- 2003-09-15 UY UY27979A patent/UY27979A1/es not_active Application Discontinuation
- 2003-09-16 US US10/663,335 patent/US7381739B2/en not_active Expired - Fee Related
-
2005
- 2005-02-08 NO NO20050664A patent/NO20050664L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501175A patent/ZA200501175B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI250150B (en) | 2006-03-01 |
| TW200413313A (en) | 2004-08-01 |
| CN1681783A (zh) | 2005-10-12 |
| ES2311721T3 (es) | 2009-02-16 |
| NZ538047A (en) | 2007-10-26 |
| CN1301970C (zh) | 2007-02-28 |
| JP4267573B2 (ja) | 2009-05-27 |
| NO20050664L (no) | 2005-04-15 |
| AR041256A1 (es) | 2005-05-11 |
| UY27979A1 (es) | 2004-03-31 |
| HK1083497A1 (en) | 2006-07-07 |
| DE60322551D1 (de) | 2008-09-11 |
| HRP20050213A2 (en) | 2006-12-31 |
| US20040072844A1 (en) | 2004-04-15 |
| EP1542973A1 (en) | 2005-06-22 |
| KR100686757B1 (ko) | 2007-02-26 |
| JP2006502177A (ja) | 2006-01-19 |
| AU2003267063B2 (en) | 2009-08-06 |
| KR20050057356A (ko) | 2005-06-16 |
| PA8582101A1 (es) | 2004-04-23 |
| RU2005111590A (ru) | 2005-11-20 |
| RU2326112C2 (ru) | 2008-06-10 |
| US7381739B2 (en) | 2008-06-03 |
| CA2498946A1 (en) | 2004-04-01 |
| ATE402923T1 (de) | 2008-08-15 |
| MXPA05002836A (es) | 2005-05-27 |
| AU2003267063A1 (en) | 2004-04-08 |
| ZA200501175B (en) | 2007-03-28 |
| WO2004026831A1 (en) | 2004-04-01 |
| BR0314363A (pt) | 2005-07-19 |
| EP1542973B1 (en) | 2008-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL377296A1 (pl) | Pochodne 1,5-diarylo-pirolo-3-karboksyamidu oraz ich zastosowanie jako modulatorów receptora kannabinoidowego | |
| ZA200501175B (en) | 2,4-substituted indoles and their use as 5-HT6 modulators | |
| SI2233483T1 (sl) | Indolni ali benzimidazolni derivati za modulacijo IkapaB-kinaze in intermediati za njihovo pripravo | |
| ZA200406362B (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials. | |
| AU2003287160A1 (en) | Substituted indoles and their use as hcv inhibitors | |
| AP2005003219A0 (en) | Pyrimidine derivatives and their use as CB2 modulators. | |
| AU2003227480A1 (en) | Modified polymers and compositions containing the same | |
| AU2003251853A1 (en) | Network attached encryption | |
| ZA200501306B (en) | 2,7-Substituted indoles and their use as 5-HT6 modulators | |
| HRP20041030A2 (en) | Benzoxazine derivatives as 5-ht6 modulators and uses thereof | |
| IL172894A0 (en) | Indol-6-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators | |
| HRP20031096A2 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| HUP0500871A3 (en) | 5-aryltetrazole compounds, compositions thereof and their use | |
| AU2003234198A8 (en) | Novel genes, compositions, and methods for modulating the unfolded protein response | |
| AU2003292508A1 (en) | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands | |
| IL172891A0 (en) | Indol-5-yl-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators | |
| AU2003263791A8 (en) | Gel coat composition | |
| AU2003258643A1 (en) | Hair colouring agent comprising indole or indoline derivatives | |
| MXPA03000644A (es) | Nuevos derivados de indol y uso como medicamentos. | |
| IL166821A0 (en) | Novel 1,4-diazabicycloalkane derivatives their preparation and use | |
| SI1551805T1 (sl) | Substituirani gama-fenil-delta-laktami in njihova uporaba | |
| IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
| TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
| SI1532141T1 (sl) | 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |